XML 57 R36.htm IDEA: XBRL DOCUMENT v3.25.1
SEGMENT INFORMATION (Tables)
3 Months Ended
Mar. 31, 2025
Segment Reporting [Abstract]  
Schedule of Information about Reportable Segments and Reconciliation of Segment Net Sales and Pre-Tax Income
The table below presents information about Edwards Lifesciences' reportable segments (in millions):
 Three Months Ended
March 31,
 20252024
Segment Net Sales  
United States$838.9 $782.1 
Europe341.8 326.0 
Japan81.8 86.0 
Rest of World150.2 135.8 
Total segment net sales$1,412.7 $1,329.9 
Cost of Sales
United States$146.0 $139.7 
Europe82.2 73.6 
Japan12.3 11.8 
Rest of World39.8 38.4 
Total segment cost of sales$280.3 $263.5 
Selling, general, and administrative expenses
United States$133.2 $115.2 
Europe73.4 71.4 
Japan16.4 26.0 
Rest of World42.1 41.4 
Total segment selling, general, and administrative expenses$265.1 $254.0 
Other Segment Items
United States$0.6 $0.7 
Europe(8.3)4.1 
Japan(4.6)0.7 
Rest of World(9.2)(1.1)
Total other segment items (a)
$(21.5)$4.4 
Segment Operating Income  
United States$559.1 $526.5 
Europe194.5 176.9 
Japan57.7 47.5 
Rest of World77.5 57.1 
Total segment operating income$888.8 $808.0 
_______________________________________________________________________________
(a)    Other segment items include research and development expenses and foreign currency.
The table below presents a reconciliation of segment operating income to consolidated pre-tax income (in millions):
 Three Months Ended
March 31,
 20252024
Pre-tax Income Reconciliation  
Segment operating income$888.8 $808.0 
Unallocated amounts:  
Corporate items(486.2)(447.0)
Separation costs (Note 3)(4.2)— 
Certain litigation expenses(10.9)(8.9)
Foreign currency7.3 (3.1)
Consolidated operating income394.8 349.0 
Non-operating income39.1 22.2 
Consolidated pre-tax income$433.9 $371.2 
Schedule of Enterprise-Wide Information
 Three Months Ended
March 31,
 20252024
Net Sales by Major Product Group  
Transcatheter Aortic Valve Replacement$1,046.6 $1,007.9 
Transcatheter Mitral and Tricuspid Therapies115.2 72.9 
Surgical Structural Heart250.9 249.1 
$1,412.7 $1,329.9